MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Abnormal pattern of brain glucose metabolism in multiple system atrophy

    G. Martí-Andrés, M. Perovnik, E. Rebec, P. Tomše, E. Prieto, T. Rus, L. Armengou-García, L. Ležaić, M. Riverol, R. Valentí, M.R Luquin, M. Trošt, J. Arbizu (Pamplona, Spain)

    Objective: To define and cross-validate the brain glucose metabolic abnormalities in patients with a clinical diagnosis of Multiple System Atrophy (MSA). Background: Despite the availability…
  • MDS Virtual Congress 2020

    Gait and motion analysis in Progressive Supranuclear Palsy

    F. Ali, S. Loushin, K. Josephs, K. Kaufman, J. Whitwell (Rochester, MN, USA)

    Objective: Evaluate gait abnormalities in progressive supranuclear palsy (PSP) with three-dimensional motion analysis. Background: PSP is associated with complex, disabling gait and balance abnormalities that…
  • MDS Virtual Congress 2020

    Navigating therapeutic landscapes with Parkinson’s disease in a scarce biomedical healthcare setting: the case of Kenya

    N. Fothergill Misbah, K. Hampshire, S. Moffatt, J. Hooker, J. Kwasa, R. Walker (Newcastle upon Tyne, United Kingdom)

    Objective: To explore how people with Parkinson’s disease (PWPD) living in Kenya manage and negotiate their treatment and care within a scarce and overwhelmed biomedical…
  • MDS Virtual Congress 2020

    Using of GcMAF in patient from Uzbekistan with MS and a concomitant liver cirrhosis due to Hepatitis B

    DrD. Mirzaeva (Tashkent, Uzbekistan)

    Objective: To study the effect of GcMAF on the general condition of patient, changes in motor activity and improvement of liver parameters after treatment. Background:…
  • MDS Virtual Congress 2020

    Patient experience interviews to inform a digital assessment of Parkinson’s disease

    A. Thomann, D. Nobbs, H. Staunton, D. Trundell, S. Winkelmann, T. Kilchenmann, C. Lansdall, C. Gossens, F. Lipsmeier, M. Lindemann, K. Taylor (Basel, Switzerland)

    Objective: The aim of this study is to generate a conceptual framework that maps patient-relevant functional limitations to behavioral measures that can be captured with…
  • MDS Virtual Congress 2020

    Sex Moderates the Effects of Neurofibrillary Tangles on Cognition for Diffuse Lewy Body Pathology

    E. Bayram, I. Litvan (La Jolla, CA, USA)

    Objective: To evaluate (1) the association between neurofibrillary tangle staging and cognition for participants with diffuse Lewy Body (LB) pathology, (2) whether this association differs…
  • MDS Virtual Congress 2020

    Clinical factors associated with neuronal loss in the substantia nigra

    R. Yilmaz, E. Bayram, C. Akbostanci (Ankara, Turkey)

    Objective: To explore (additional) clinical features associated with nigral neuronal loss that could potentially be included in the criteria for prodromal Parkinson’s disease (PD). Background:…
  • MDS Virtual Congress 2020

    Deep brain stimulation and cognitive decline in Parkinson’s disease: The predictive value of Alternate Fluency test

    R. Ferrucci, F. Mameli, F. Ruggiero, M. Reitano, S. Marceglia, M. Massei, L. Borellini, F. Cogiamanian, T. Bocci, M. Locatelli, S. Barbieri, A. Averna, A. Priori (Milan, Italy)

    Objective: To study the impact of subthalamic nucleus deep brain stimulation (STN-DBS) on executive function using Alternate Fluency Test (AFT) and to investigate predictors for…
  • MDS Virtual Congress 2020

    Comparative analysis of cognitive function between unilaterally and bilaterally affected Parkinson’s disease

    J. Lee, G.S Kim (Goyang-si, Republic of Korea)

    Objective: To compare the cognitive function between unilateral and bilateral PD to identify whether worse cognitive impairment underlies in the bilateral group who had greater…
  • MDS Virtual Congress 2020

    Increased neurofilament light chain plasma levels as a biological marker of mild cognitive impairment in Parkinson’s disease

    J. Pagonabarraga, R. Perez-Gonzalez, H. Bejr-Kasem, J. Marin-Lahoz, A. Horta-Barba, I. Aracil-Bolaños, F. Sampedro, S. Martinez-Horta, J. Perez-Perez, B. Pascual-Sedano, J. Kulisevsky (Barcelona, Spain)

    Objective: To examine whether PD-MCI patients have increased plasma neurofilament light chain (NfL) levels compared to PD with normal cognition (PD-NC) and healthy controls (HC).…
  • 1
  • 2
  • 3
  • …
  • 149
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley